Peter B. Corr, Ph.D., Named Executive Chairman UNIVERSITY PARK, Fla., Nov. 1, 2023 /PRNewswire/ -- Lakewood-Amedex Inc., a privately held, clinical-stage pharmaceutical discovery and...
Lakewood-Amedex’s Second Clinical Trial for DFU Using New Nu-3 Gel Formulation Top Line Results Expected in December 2022 SARASOTA, Fla., April 5, 2022 -...
Elects Thomas Pfisterer and Douglas Manion, MD, FRCP(C), to the Board of Directors SARASOTA, Fla., January 25, 2022 — Lakewood-Amedex Inc., a privately held, clinical stage...
Lakewood-Amedex Therapeutics Inc. today announced that Peter B. Corr, Ph.D., has been elected as Chairman of the Board of Directors of the company. Dr....